Scalable recombinant adeno-associated virus production using recombinant herpes simplex virus type 1 coinfection of suspension-adapted mammalian cells.
about
Large-scale adeno-associated viral vector production using a herpesvirus-based system enables manufacturing for clinical studiesManufacturing of recombinant adeno-associated viral vectors for clinical trialsProgress with Recombinant Adeno-Associated Virus Vectors for Gene Therapy of Alpha-1 Antitrypsin DeficiencyPreclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production methodPhase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim results.Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin.Progress and challenges in viral vector manufacturingA Regulatory Element Near the 3' End of the Adeno-Associated Virus rep Gene Inhibits Adenovirus Replication in cis by Means of p40 Promoter-Associated Short Transcripts.Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of AchromatopsiaSafety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia.Recombinant adeno-associated virus vectors in the treatment of rare diseases.OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapyManufacturing of recombinant adeno-associated viral vectors: new technologies are welcomeCharacteristics of Minimally Oversized Adeno-Associated Virus Vectors Encoding Human Factor VIII Generated Using Producer Cell Lines and Triple Transfection.Adeno-Associated Virus Gene Therapy for Liver Disease.Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.Manufacturing of recombinant adeno-associated viruses using mammalian expression platforms.Adeno-Associated Virus (AAV) as a Vector for Gene Therapy.Clearance and characterization of residual HSV DNA in recombinant adeno-associated virus produced by an HSV complementation system.Distribution of AAV8 particles in cell lysates and culture media changes with time and is dependent on the recombinant vectorA scalable method for the production of high-titer and high-quality adeno-associated type 9 vectors using the HSV platform.Strategies to optimize capsid protein expression and single-stranded DNA formation of adeno-associated virus in Saccharomyces cerevisiae.Sodium Chloride Enhances Recombinant Adeno-Associated Virus Production in a Serum-Free Suspension Manufacturing Platform Using the Herpes Simplex Virus System.Evidence for pH-dependent protease activity in the adeno-associated virus capsid.Molecular design for recombinant adeno-associated virus (rAAV) vector production.A Robust System for Production of Superabundant VP1 Recombinant AAV Vectors.Pharmacology of Recombinant Adeno-associated Virus Production.
P2860
Q24630417-198B2FE6-1E31-403C-9C19-7D0FA9F357CDQ26750799-C4236027-E39E-4E20-B0BB-11B4224AC142Q28085148-E1CB1551-9E9E-4052-840D-6E3CB7EB1691Q34589262-E65A767C-C3B1-4DC8-A2E0-BBC1FBA4EE1AQ35496285-0A3F1183-F373-4905-9A70-BF0288B3CCDFQ36677162-172C37E4-738F-4258-9802-26FF7C1DA249Q36713761-B4204BD2-3404-4463-8DD3-D56CB6A425C7Q36736426-5E6A048E-A0D0-46CE-8AB4-0A94343B189DQ36852206-A6E00393-8DE2-4E04-880B-D6E7B47BA364Q36852220-5587042B-1A71-42A7-A910-FE0BFAD0D491Q37279525-E4C19738-A1D6-476B-99BE-FFB1366B75B0Q37640503-7E64B287-96F2-4822-9FAB-3125CC98740CQ38505122-B86CDF92-C67C-40AB-B3F9-739416B1A160Q38717682-6CACD4C3-ECF0-4DB9-8483-E66D67E7F257Q38789554-55599623-68D8-47AD-BC90-1F6ED4C888E9Q38830211-7DC4A53C-58AF-4D8B-A9B4-44B067A54CE4Q39126013-FF57B34A-C641-406A-AC54-B1EE99D91C23Q39409371-49E899A8-C8C3-4A92-94A8-073D6EC68A10Q39674124-C71FA27F-4028-4FDB-824E-C2756BB9E216Q39680091-9D567646-2E6C-4446-AF08-1FC5E8B9FD15Q39737661-20280AAC-3348-498D-8E20-75AE7AD3D665Q40161791-CCE19FB8-01C3-4E3D-B0D5-B7260BC7FAF4Q40360243-DC76F801-3F2B-4A5D-BEC2-FC5FAB4B4D22Q41578092-F925AB13-A961-46B9-90E1-382BB71C1B81Q45323804-281AB858-F645-406F-9D01-DF03F1FBCF3EQ47115558-9EC06777-E407-4F37-BAC7-5414C57FE3F1Q52717185-D0DD4B9C-DACD-4CCC-811F-3456378BCA6E
P2860
Scalable recombinant adeno-associated virus production using recombinant herpes simplex virus type 1 coinfection of suspension-adapted mammalian cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Scalable recombinant adeno-ass ...... nsion-adapted mammalian cells.
@en
Scalable recombinant adeno-ass ...... nsion-adapted mammalian cells.
@nl
type
label
Scalable recombinant adeno-ass ...... nsion-adapted mammalian cells.
@en
Scalable recombinant adeno-ass ...... nsion-adapted mammalian cells.
@nl
prefLabel
Scalable recombinant adeno-ass ...... nsion-adapted mammalian cells.
@en
Scalable recombinant adeno-ass ...... nsion-adapted mammalian cells.
@nl
P2093
P356
P1433
P1476
Scalable recombinant adeno-ass ...... nsion-adapted mammalian cells.
@en
P2093
Darby L Thomas
David R Knop
Gabor Veres
Guo-jie Ye
Justine Niamke
Lijun Wang
Marina M Scotti
P304
P356
10.1089/HUM.2009.004
P577
2009-08-01T00:00:00Z